Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022:271:115-135.
doi: 10.1007/164_2020_395.

Biased Ligands at the Kappa Opioid Receptor: Fine-Tuning Receptor Pharmacology

Affiliations
Review

Biased Ligands at the Kappa Opioid Receptor: Fine-Tuning Receptor Pharmacology

Tarsis F Brust. Handb Exp Pharmacol. 2022.

Abstract

The kappa opioid receptor (KOR) is a G protein-coupled receptor (GPCR) that can signal through multiple signaling pathways. KOR agonists are known to relieve pain and itch, as well as induce dysphoria, sedation, hallucinations, and diuresis. As is the case with many other GPCRs, specific signaling pathways downstream of the KOR have been linked to certain physiological responses induced by the receptor. Those studies motivated the search and discovery of a number of KOR ligands that preferentially activate one signaling pathway over another. Such compounds are termed functionally selective or biased ligands, and may present a way of inducing desired receptor effects with reduced adverse reactions. In this chapter, I review the molecular intricacies of KOR signaling and discuss the studies that have used biased signaling through the KOR as a way to selectively modulate in vivo physiology.

Keywords: Functional selectivity; G protein-coupled receptor; G proteins; Kappa opioid receptor; Ligand bias; Pain; βarrestin.

PubMed Disclaimer

References

    1. Allen J et al (2011) Discovery of beta-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy. Proc Natl Acad Sci U S A 108:18488–18493 - PubMed - PMC
    1. Avidor-Reiss T et al (1995) kappa-opioid receptor-transfected cell lines: modulation of adenylyl cyclase activity following acute and chronic opioid treatments. FEBS Lett 361:70–74 - PubMed
    1. Bedini A et al (2020) Functional selectivity and antinociceptive effects of a novel KOPr agonist. Front Pharmacol 11:188 - PubMed - PMC
    1. Birnbaumer L (2007) Expansion of signal transduction by G proteins. The second 15 years or so: from 3 to 16 alpha subunits plus betagamma dimers. Biochim Biophys Acta 1768:772–793 - PubMed
    1. Black JW, Leff P (1983) Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci 220:141–162 - PubMed

LinkOut - more resources